AKTS

Aktis Oncology, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$17.37

Market Cap

$925.77M

Beta

0.00

P/E

—

Div Yield

—

Sector Median P/E

—

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)+0.00%

Revenue CAGR 3Y+0.00%

P/E Ratio—

PEG Ratio—

FCF Yield+0.00%

Debt / Equity—

Interest Coverage—

No credit card required

Already have an account? Sign in to view the full analysis for AKTS.